Anatomy-Guided Nanomedicines Aim to Deliver Cancer Drugs Where They Matter Most
A new review proposes an anatomy-guided framework in which the bladder, prostate and kidney each demand distinct nanomedicine designs to ...
A new review proposes an anatomy-guided framework in which the bladder, prostate and kidney each demand distinct nanomedicine designs to ...
Bridging studies confirm that the Ventana MMR RxDx Panel and FoundationOne CDx reliably identify dMMR/MSI-H tumor patients likely to respond ...
Researchers at Lund University have shown that precision-cut slices of bladder tumors keep their immune cells alive and functional for ...
A new case series and literature review suggest the interleukin-4 and interleukin-13 blocker dupilumab may bring relief to patients with ...
A comprehensive pan-cancer study identifies the ribosome biogenesis enzyme DIMT1 as a prognostic and immune-associated biomarker whose depletion suppresses gastric ...
A first-in-human trial shows that the conformation-selective PI3Kδ inhibitor roginolisib is well tolerated in advanced cancers and is associated with ...
The Alliance for Clinical Trials in Oncology is marking Prostate Cancer Awareness Month by highlighting a portfolio of clinical trials ...
A new commentary in BMC Cancer warns that pan-cancer studies treating CFH as a single cancer biomarker have been measuring ...
A rat study shows that spatially fractionated minibeam radiation, unlike conventional radiotherapy, preserves the efficacy of CD19-directed CAR T cells ...
A new study shows that the RNA cap-modifying enzyme PCIF1 drives tumor growth and radioresistance, and that removing its m6Am ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine